What is thyroid cancer?
The thyroid is a hormone-producing gland at the front of the neck. Papillary thyroid cancer is the most common subtype; follicular and oncocytic cancers are also differentiated thyroid cancers. Medullary cancer begins in parafollicular C cells and may be linked to an inherited RET change, while anaplastic thyroid cancer is rare and rapidly growing. Subtype matters because patterns of spread, staging, biomarkers, and treatment differ. Exposure to ionizing radiation, certain inherited syndromes, and family history increase risk for some thyroid cancers, but many people have no clear risk factor. Most thyroid nodules are benign, so evaluation aims to identify which nodules need sampling or surveillance. Follow-up may use neck ultrasound, thyroid-related blood tests, thyroglobulin for differentiated cancer, or calcitonin and carcinoembryonic antigen for medullary cancer. Persistent or recurrent disease may remain local, involve lymph nodes, or spread to lungs, bone, and other organs, requiring subtype-specific multidisciplinary care.
Signs and symptoms
Thyroid cancer may cause no early symptoms and may be found as a nodule during an examination or imaging for another reason. Possible signs include a lump or swelling in the neck, enlarging thyroid nodule, persistent hoarseness or voice change, trouble swallowing, pain with swallowing, neck discomfort, or trouble breathing. Enlarged neck lymph nodes may be present. Thyroid hormone levels are often normal even when cancer is present. Rapid neck enlargement, noisy breathing, or worsening breathing difficulty requires prompt assessment, particularly because anaplastic thyroid cancer can progress quickly. Most thyroid nodules are benign, and these symptoms can also come from noncancer conditions such as goiter, thyroiditis, cysts, infection, or vocal-cord disorders. Ultrasound and, when indicated, biopsy are needed to clarify the cause.
Diagnosis and staging
Evaluation commonly includes neck examination, thyroid ultrasound, and thyroid-stimulating hormone testing. Ultrasound features and nodule size guide whether fine-needle aspiration is recommended. Cytology may identify cancer or an indeterminate result; molecular testing can sometimes refine diagnosis or guide surgery. After diagnosis, imaging and examination assess lymph nodes and possible spread. Pathology establishes subtype, tumor size, invasion, margins, and nodal findings. Differentiated thyroid cancers use age-aware TNM staging, while medullary and anaplastic cancers have distinct staging rules. RET germline testing is important for medullary thyroid cancer because a hereditary result can affect the patient and relatives. Tumor testing for RET, BRAF, NTRK, or other alterations may guide therapy in advanced disease. Care depends on subtype, stage, molecular findings, iodine avidity, symptoms, prior treatment, health, and patient preferences.
Established treatment paths
Surgery is the main treatment for many thyroid cancers and may involve removal of one lobe or the whole thyroid, with lymph-node surgery when indicated. The extent is individualized to tumor size, location, subtype, nodal disease, imaging, and patient factors. After total thyroidectomy for selected differentiated cancers, radioactive iodine may treat remaining iodine-avid thyroid tissue or cancer. Thyroid hormone replacement is required after total thyroidectomy and may be dosed to suppress thyroid-stimulating hormone in some differentiated cancers. Small, very low-risk papillary cancers may be candidates for active surveillance in experienced programs. External-beam radiation is used selectively for unresectable, residual, recurrent, or anaplastic disease. Advanced cancers may receive targeted drugs chosen by subtype and actionable alterations; multikinase inhibitors, RET inhibitors, BRAF/MEK therapy, or NTRK inhibitors apply in specific settings. Chemotherapy and immunotherapy have more limited or selected roles. Anaplastic cancer requires rapid multidisciplinary planning, airway assessment, and early molecular testing because actionable results can change initial therapy. Treatment depends on type, stage, biomarkers, iodine uptake, symptoms, health, goals, and treatment response.
Supportive care
Supportive care includes voice and swallowing assessment after neck surgery, calcium monitoring, thyroid-hormone management, scar and pain care, and help with fatigue or anxiety. New tingling, muscle cramps, breathing difficulty, neck swelling, or voice change after surgery should be reported promptly. Dietitian support may help during swallowing problems or radiation. Dental care can be relevant before head-and-neck radiation. People receiving targeted or systemic therapies need monitoring tailored to the drug, including blood pressure, skin, gastrointestinal, liver, or heart effects. Follow-up tests should match the thyroid cancer subtype and treatment history.
Profiles documenting thyroid cancer care
These profiles mention a matching cancer specialty in their published materials. Browse their locations, reported services, and practical details.
No clinic profile is connected to this guide yet. The wider directory may still offer useful places to explore.
Sources
Source information checked: 2026-09-29. The links below identify the public and clinic-provided materials used for this page.
- NCI: Thyroid Cancer Treatment (Patient Version) ↗Checked 2026-09-29
- NCI: Thyroid Cancer Treatment (Professional Version) ↗Checked 2026-09-29
- NCI: Side Effects of Cancer Treatment ↗Checked 2026-09-29
How Cancer Clinic Finder compiles information · Suggest a factual correction
